Non-haematological uses of cord blood stem cells

Research output: Contribution to journalReview article

64 Scopus citations

Abstract

Summary Embryonic stem (ES) cell therapies are often promoted as the optimal stem cell source for regenerative medicine applications because of their ability to develop into any tissue in the body. Unfortunately, ES cell applications are currently limited by ethical, political, biological and regulatory hurdles. However, multipotent non-ES cells are available in large numbers in umbilical cord blood (CB). CB stem cells are capable of giving rise to hematopoietic, epithelial, endothelial and neural tissues both in vitro and in vivo. Thus, CB stem cells are amenable to treat a wide variety of diseases including cardiovascular, ophthalmic, orthopaedic, neurological and endocrine diseases. In addition, the recent use of CB in several regenerative medicine clinical studies has demonstrated its pluripotent nature. Here we review the latest developments in the use of CB in regenerative medicine. Examples of these usages include cerebral palsy and type I diabetes. The numbers of individuals affected with each of these diseases are estimated at 10 000 infants diagnosed with cerebral palsy annually and 15 000 youths diagnosed with type 1 diabetes annually. A summary of the initial results from such clinical studies using autologous cord blood stem cells will be presented.

Original languageEnglish (US)
Pages (from-to)177-184
Number of pages8
JournalBritish Journal of Haematology
Volume147
Issue number2
DOIs
StatePublished - Oct 1 2009

Keywords

  • Regenerative medicine
  • Stem cells
  • Tissue engineering
  • Umbilical cord blood

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Non-haematological uses of cord blood stem cells'. Together they form a unique fingerprint.

  • Cite this